Abeona Therapeutics grants restricted stock to new employees as hiring incentive under Nasdaq rules.

Abeona Therapeutics announced it granted restricted stock awards to five new non-executive employees as an inducement to join the company, totaling up to 9,000 shares. These shares will vest over three years, contingent on continued employment. This move aligns with Nasdaq Listing Rule 5635(c)(4) and aims to attract talent for the biopharmaceutical firm's growth. Abeona specializes in cell and gene therapies, including its commercial product ZEVASKYN for rare skin disease treatment.